Paula Soteropoulos is Director of uniQure N.V.. Currently has a direct ownership of 20,203 shares of QURE, which is worth approximately $343,046. The most recent transaction as insider was on Jun 13, 2024, when has been sold 2,220 shares (Ordinary Shares) at a price of $5.14 per share, resulting in proceeds of $11,410. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.2K
0% 3M change
9.9% 12M change
Total Value Held $343,046

Paula Soteropoulos Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 13 2024
SELL
Open market or private sale
$11,410 $5.14 p/Share
2,220 Reduced 9.9%
20,203 Ordinary Shares
Jun 16 2023
SELL
Open market or private sale
$43,202 $18.99 p/Share
2,275 Reduced 9.21%
22,423 Ordinary Shares
Jun 13 2023
BUY
Grant, award, or other acquisition
-
8,700 Added 26.05%
24,698 Ordinary Shares
Feb 27 2023
SELL
Open market or private sale
$7,668 $19.97 p/Share
384 Reduced 2.34%
15,998 Ordinary Shares
Jan 18 2023
SELL
Open market or private sale
$135,540 $22.59 p/Share
6,000 Reduced 26.81%
16,382 Ordinary Shares
Jan 18 2023
BUY
Exercise of conversion of derivative security
$32,220 $5.37 p/Share
6,000 Added 21.14%
22,382 Ordinary Shares
Dec 14 2022
SELL
Open market or private sale
$89,034 $23.43 p/Share
3,800 Reduced 18.83%
16,382 Ordinary Shares
Dec 14 2022
BUY
Exercise of conversion of derivative security
-
3,800 Added 15.85%
20,182 Ordinary Shares
Dec 13 2022
SELL
Open market or private sale
$70,350 $23.45 p/Share
3,000 Reduced 15.48%
16,382 Ordinary Shares
Dec 13 2022
BUY
Exercise of conversion of derivative security
$16,110 $5.37 p/Share
3,000 Added 13.4%
19,382 Ordinary Shares
Nov 29 2022
SELL
Open market or private sale
$157,356 $25.38 p/Share
6,200 Reduced 27.46%
16,382 Ordinary Shares
Nov 29 2022
BUY
Exercise of conversion of derivative security
-
6,200 Added 21.54%
22,582 Ordinary Shares
Jun 15 2022
BUY
Grant, award, or other acquisition
-
9,080 Added 35.66%
16,382 Ordinary Shares
Feb 28 2022
SELL
Open market or private sale
$10,055 $16.87 p/Share
596 Reduced 7.55%
7,302 Ordinary Shares
Feb 24 2022
BUY
Grant, award, or other acquisition
-
1,534 Added 16.26%
7,898 Ordinary Shares
Mar 02 2021
SELL
Open market or private sale
$18,950 $37.6 p/Share
504 Reduced 7.34%
6,364 Ordinary Shares
Feb 25 2021
BUY
Grant, award, or other acquisition
-
2,382 Added 25.75%
6,868 Ordinary Shares

Also insider at

RLYB
Rallybio Corp Healthcare
MGTA
Magenta Therapeutics, Inc. Healthcare
PS

Paula Soteropoulos

Director
Amsterdam, P7

Track Institutional and Insider Activities on QURE

Follow uniQure N.V. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells QURE shares.

Notify only if

Insider Trading

Get notified when an Uni Qure N.V. insider buys or sells QURE shares.

Notify only if

News

Receive news related to uniQure N.V.

Track Activities on QURE